Nevus  >>  fosaprepitant  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fosaprepitant / Generic mfg.
NCT01874119: Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma

Terminated
2b
13
US
Fosaprepitant, Emend
St. Louis University, Merck Sharp & Dohme LLC
Chemotherapy-induced Nausea and Vomiting
12/15
12/15

Download Options